
Iodixanol - Cas 92339-11-2 | 99% Assay High-efficiency Contrast Agent For Cardiovascular Angiography And Intravenous Urography
Price:
Get Latest Price
In Stock
Product Overview
Key Features
Specifications:
Assay:99%
CAS: 92339-11-2
IODIXANOL; 1 3-benzenedicarboxamide 5 5'-((2-hydroxy-1 3-propanediyl)bis(acetylimino))bis; N'-bis(2 3-dihydroxypropyl)-2 4 6-triiodo-(; 1 3-Benzenedicarboxamide 5 5'-[(2-hydroxy-1 3-propanediyl)bis(acetylimino)]bis[N N'-bis(2 3-dihydroxypropyl)-2 4 6-triiodo-; 2-5410-3A; OptiPrep; Visipaque; 5 5'-((2-Hydroxy-1 3-propanediyl)bis(acetylimino))bis(N N'-bis(2 3-dihydroxypropyl)-2 4 6-triiodo-1 3-benzenedicarboxamide
MF: C35H44I6N6O15
MW: 1550.18
Melting point: 262-267A C (DEC. )
Indications
This product is applicable within the cone contrast there are for intravenous urography cardiovascular angiography.
Description
Iodixanol injection with a contrast agent for angiography within the cone cardiovascular angiography intravenous urography. Its principle is the combination of iodine absorption of X-rays in the blood vessels or tissue resulting image is displayed. Iodixanol less influence on cardiovascular parameters and blood flow stocks but for the elderly kidney dysfunction Coronary patients should pay attention to.
Our advantage:
1. Packing :
A: Order under 20kg
Arranged by discreet packing.
B: Order above 50kg
If you want ship by air or sea is not a problem . Full set of documents are available.
Company Details
Focusing on a customer-centric approach Wuhan Science and Technology Development Co. Ltd. has a pan-India presence and caters to a huge consumer base throughout the country. Buy Pharmaceutical Raw Materials & Ingredients in bulk from Wuhan Science and Technology Development Co. Ltd. at Trade India quality-assured products.
Business Type
Exporter
Establishment
2001
Related Products
Explore Related Categories
More Product From This seller
Seller Details
Wuhan, Hubei
Ms. Sadiya Sun
Address
496 Zhongshan Road Wuhan Hubei 430064 China
active pharmaceutical ingredients in Wuhan
Report incorrect details